Altimmune, Inc. (ALT)
5.54
+0.02
(+0.36%)
USD |
NASDAQ |
Dec 10, 15:21
Altimmune EPS Diluted (Quarterly): -0.2126 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Viking Therapeutics, Inc. | -0.8083 |
| Eli Lilly & Co. | 6.211 |
| Pfizer Inc. | 0.6197 |
| Terns Pharmaceuticals, Inc. | -0.2686 |
| Rhythm Pharmaceuticals, Inc. | -0.8192 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -19.01M |
| Revenue (Quarterly) | 0.005M |
| Total Expenses (Quarterly) | 19.02M |
| Enterprise Value | 381.06M |
| Gross Profit Margin (Quarterly) | -440.0% |
| Profit Margin (Quarterly) | -380.3K% |
| Earnings Yield | -19.29% |
| Normalized Earnings Yield | -19.29 |